[Federal Register Volume 69, Number 189 (Thursday, September 30, 2004)]
[Notices]
[Page 58445]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-21920]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) and the Acting Assistant Secretary for Health have taken final 
action in the following case:
    Charles N. Rudick, Northwestern University: Based on the report of 
an investigation conducted by Northwestern University (NU Report) and 
additional analysis conducted by ORI in its oversight review, PHS found 
that Charles N. Rudick, Graduate Student, Department of Neurobiology 
and Physiology at NU (Respondent), engaged in scientific misconduct in 
research supported by National Institute of Neurological Disorders and 
Stroke (NINDS), National Institutes of Health (NIH), grant R29 NS37324, 
``Estrogen-induced hippocampal seizure susceptibility,'' and National 
Institute of General Medical Sciences (NIGMS), NIH, grant T32 GM08061, 
``Cellular and Molecular Basis of Disease Training Program.''
    Specifically, PHS found that Mr. Rudick falsified illustrations in 
Photoshop pertaining to unpublished traces of electrophysiological 
recordings of inhibitory postsynaptic currents.
    Mr. Rudick has entered into a Voluntary Exclusion Agreement 
(Agreement ) in which he has voluntarily agreed for a period of three 
(3) years, beginning on September 14, 2004:
    (1) To exclude himself from serving in any advisory capacity to PHS 
including but not limited to service on any PHS advisory committee, 
board, and/or peer review committee, or as a consultant; and
    (2) That any institution which submits an application for PHS 
support for a research project on which the Respondent's participation 
is proposed or which uses the Respondent in any capacity on PHS 
supported research, or that submits a report of PHS-funded research in 
which the Respondent is involved, must concurrently submit a plan for 
supervision of the Respondent's duties to the funding agency for 
approval. The supervisory plan must be designed to ensure the 
scientific integrity of the Respondent's research contribution. 
Respondent agrees to ensure that a copy of the supervisory plan is also 
submitted to ORI by the institution. Respondent agrees that he will not 
participate in any PHS-supported research until such a supervision plan 
is submitted to and accepted by ORI.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (301) 443-5330.

Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. 04-21920 Filed 9-29-04; 8:45 am]
BILLING CODE 4150-31-P